Physician profile
Cheryl Rips
NPI 1356347371
$2,513.68
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $102 · 2021: $115 · 2022: $1,435 · 2023: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $1,220.34 | 2022 | |
| Abbvie INC. | $333.96 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Daiichi Sankyo INC. | $263.36 | 2019-2023 | Injectafer |
| Medtronic, INC. | $97.58 | 2022-2023 | Truclear |
| Hologic Sales and Service, LLC | $86.94 | 2019-2023 | Aptima, Thinprep 2000 Processor, Third Wave |
| Allergan, INC. | $67.00 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $63.80 | 2021-2023 | |
| Astellas Pharma US INC | $57.46 | 2019-2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $54.64 | 2019-2022 | |
| Therapeuticsmd, INC. | $39.92 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $35.54 | 2023 | Myfembree |
| Myovant Sciences INC. | $34.84 | 2022 | |
| Agile Therapeutics, INC. | $34.09 | 2023 | Twirla |
| Pfizer INC. | $31.35 | 2022-2023 | |
| Covidien LP | $25.19 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $23.75 | 2023 | Monoferric |
| Mission Pharmacal Company | $19.39 | 2019 | |
| Boston Scientific Corporation | $13.13 | 2019 | |
| Radius Health, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Rips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.